Lensar (LNSR) Interest Coverage Ratio (QoQ) (2019 - 2026)
Lensar (LNSR) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 331.62% |
| Dec 31, 2025 | 27.12% |
| Sep 30, 2025 | -34.78% |
| Jun 30, 2025 | -21.88% |
| Mar 31, 2025 | -88.53% |
| Dec 31, 2024 | 69.89% |
| Sep 30, 2024 | 85.81% |
| Jun 30, 2024 | -582.18% |
| Mar 31, 2024 | 90.65% |
| Dec 31, 2023 | -1,665.79% |
| Sep 30, 2023 | 83.43% |
| Jun 30, 2023 | -180.17% |
| Mar 31, 2023 | 78.79% |
| Dec 31, 2022 | -501.65% |
| Sep 30, 2022 | 57.80% |
| Jun 30, 2022 | -1.72% |
| Mar 31, 2022 | 79.48% |
| Dec 31, 2021 | -556.55% |
| Sep 30, 2021 | -40.91% |
| Jun 30, 2021 | 15.87% |